è¡ç³å¤ã«å¿ãã¦åããä¼ãè³¢ãã¤ã³ã¹ãªã³ãNovo Nordisk社ãéçº ã» ãã¿ã¸ã®æä¸è©¦é¨ã§ä½è¡ç³ãå¼ãèµ·ãããã¨ãªãè¡ç³å¤ãã»ã©ããä¸ããããã¨ã示ãããæ¨è¨è¼ãè¨æ£ãã¾ããã æ¦ç°è¬åãæã«å ¥ãããWave社ã®ãã³ãã³ãã³ç è¬ã®Ph1/2試é¨ã§æå¿ããã ã» mHTTãå¤ç°ãã³ãã³ãã³ã§ãããã¨ããããããã«ãã¾ããã Rocheã®PI3Ké»å®³å¤inavolisibè¾¼ã¿ä¹³çæ²»çPh3試é¨ãã¾ãã¯ç¡å¢æªçåæ¹åéæ 㻠誤解ãè¨æ£ãã¾ããï¼å åæ³æ²»çââè¡å¾âå åæ³æ²»çï¼ 2017-12-05 - 10æã«ç±³å½FDAã«æ¿èªç³è«ãåçãããAllergan/Gedeon Richterã®åå®®çè «è¬Esmyaï¼ulipristalï¼ä½¿ç¨æ£è ã®é度èéå®³å ±åãåãã¦æ¬§å·å»è¬ååºï¼EMAï¼ãåå¤ã®èª¿æ»ãå§ãã¾ããã (3 段è½, 331 æå) [å ¨æãèªãã«ã¯ææä¼å¡ç»é²ãå¿ è¦ã§ã] [æ
{{#tags}}- {{label}}
{{/tags}}